News
Lilly Drug Saves Muscle When Added to Wegovy Weight-Loss Shot
Patients who took an experimental drug from Eli Lilly & Co. together with Novo Nordisk A/S’s Wegovy maintained muscle while losing weight, offering a potential solution to one of the key problems that’s emerged with popular obesity shots.
Novo Nordisk's Weight-loss Drug Trial and Eli Lilly's Promising Obesity Treatment
Novo Nordisk reported mostly mild side effects from its experimental weight-loss drug CagriSema, though results upset investors. Eli Lilly anticipates third-quarter results for its obesity treatment orforglipron in non-diabetics,
Some doctors are concerned that patients taking weight loss drugs like Wegovy may be losing too much lean mass. A combination ...
New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...
Compounded GLP-1s are still accessible on telehealth sites, despite an agreement with Eli Lilly to cease copycat sales.
9don MSN
Eli Lilly ( LLY 0.90%) is one of the undisputed leaders in the fast-growing market for weight-management medicines. Following ...
An obesity drug from China helped patients lose a lot of weight in a late-stage clinical trial, making it a prospective new ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback